Merck Foundation Chief Executive Officer (CEO) advanced Cancer Care in Africa by providing 194 Oncology Scholarships in ...
Three mega-cap names recently announced billions in share repurchase authorizations. Mega-cap generally refers to stock with ...
In the bustling tech hubs and corporate centres of India, a quiet revolution is taking place. A new generation of women ...
The protein, called granzyme K, whose role until now was unclear, drives inflammation and tissue damage in a range of ...
Vanguard High Dividend Yield Index Fund ETF Shares is a conservative growth fund. See why VYM's limited tech exposure impacts ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.
Under terms of the deal, Epitopea and Merck will work to identify Cryptigen tumor-specific antigens through Epitopea’s CryptoMap platform.
Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the ...
A lawyer for the plaintiff in the case said Merck agreed to halting the trial because his team feared that extensive ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...